NEU 1.54% $19.86 neuren pharmaceuticals limited

european patent, page-11

  1. 519 Posts.
    lightbulb Created with Sketch. 1226
    finally we arrived at the final stages. the European patent is drawn up definitively and with the payment of a few taxes by Neuren, the European patent 2591 in its fullness of content will find the official status. this was the last missing element to the complete intellectual property package for 2591 that the company can offer to a possible partner (or buyer) to finance the studies already widely planned.the official date on which the defined composition of the patent materialized dates back to last November 9 and this perhaps explains the price peak of 2.62 $ reached at that moment by the market.soon the company should announce the official status of the concession.I have always considered Neuren's intellectual heritage very important, so from now and by virtue of its intrinsic potential, I expect a strong position on the market from those who until now have waited for all the pieces to be in place to discount the true value of this company.

    https://register.epo.org/application?number=EP14829224&lng=en&tab=doclist

    https://register.epo.org/application?documentId=E318BPRS1977DSU&number=EP14829224&lng=en&npl=false
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.